These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19181527)

  • 1. Synthesis and SAR studies of trisubstituted purinones as potent and selective adenosine A2A receptor antagonists.
    Shao Y; Cole AG; Brescia MR; Qin LY; Duo J; Stauffer TM; Rokosz LL; McGuinness BF; Henderson I
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1399-402. PubMed ID: 19181527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,3-dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships.
    Fernández F; Caamaño O; Isabel Nieto M; López C; García-Mera X; Stefanachi A; Nicolotti O; Isabel Loza M; Brea J; Esteve C; Segarra V; Vidal B; Carotti A
    Bioorg Med Chem; 2009 May; 17(10):3618-29. PubMed ID: 19398343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-(2-Furanyl)-9H-purin-2-amine derivatives as A2A adenosine antagonists.
    Kiselgof E; Tulshian DB; Arik L; Zhang H; Fawzi A
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2119-22. PubMed ID: 15808481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic studies on selective adenosine A2A receptor antagonists: synthesis and structure-activity relationships of novel benzofuran derivatives.
    Saku O; Saki M; Kurokawa M; Ikeda K; Takizawa T; Uesaka N
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1090-3. PubMed ID: 20034788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship studies of a new series of imidazo[2,1-f]purinones as potent and selective A(3) adenosine receptor antagonists.
    Baraldi PG; Preti D; Tabrizi MA; Romagnoli R; Saponaro G; Baraldi S; Botta M; Bernardini C; Tafi A; Tuccinardi T; Martinelli A; Varani K; Borea PA
    Bioorg Med Chem; 2008 Dec; 16(24):10281-94. PubMed ID: 19006671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel 7-imino-2-thioxo-3,7-dihydro-2H-thiazolo [4,5-d] pyrimidine derivatives as adenosine A2A receptor antagonists.
    Luthra PM; Mishra CB; Jha PK; Barodia SK
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1214-8. PubMed ID: 20018509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The discovery and synthesis of novel adenosine receptor (A(2A)) antagonists.
    Matasi JJ; Caldwell JP; Hao J; Neustadt B; Arik L; Foster CJ; Lachowicz J; Tulshian DB
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1333-6. PubMed ID: 15713381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of a series of 8-(substituted-phenyl)xanthines and a study on the effects of substitution pattern of phenyl substituents on affinity for adenosine A(1) and A(2A) receptors.
    Bansal R; Kumar G; Gandhi D; Young LC; Harvey AL
    Eur J Med Chem; 2009 May; 44(5):2122-7. PubMed ID: 19036477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor.
    Stefanachi A; Brea JM; Cadavid MI; Centeno NB; Esteve C; Loza MI; Martinez A; Nieto R; Raviña E; Sanz F; Segarra V; Sotelo E; Vidal B; Carotti A
    Bioorg Med Chem; 2008 Mar; 16(6):2852-69. PubMed ID: 18226909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.
    Minetti P; Tinti MO; Carminati P; Castorina M; Di Cesare MA; Di Serio S; Gallo G; Ghirardi O; Giorgi F; Giorgi L; Piersanti G; Bartoccini F; Tarzia G
    J Med Chem; 2005 Nov; 48(22):6887-96. PubMed ID: 16250647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel bicyclic piperazine derivatives of triazolotriazine and triazolopyrimidines as highly potent and selective adenosine A2A receptor antagonists.
    Peng H; Kumaravel G; Yao G; Sha L; Wang J; Van Vlijmen H; Bohnert T; Huang C; Vu CB; Ensinger CL; Chang H; Engber TM; Whalley ET; Petter RC
    J Med Chem; 2004 Dec; 47(25):6218-29. PubMed ID: 15566292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.
    Mantri M; de Graaf O; van Veldhoven J; Göblyös A; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Link R; de Vries H; Beukers MW; Brussee J; Ijzerman AP
    J Med Chem; 2008 Aug; 51(15):4449-55. PubMed ID: 18637670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonists of the human A(2A) receptor. Part 6: Further optimization of pyrimidine-4-carboxamides.
    Gillespie RJ; Bamford SJ; Clay A; Gaur S; Haymes T; Jackson PS; Jordan AM; Klenke B; Leonardi S; Liu J; Mansell HL; Ng S; Saadi M; Simmonite H; Stratton GC; Todd RS; Williamson DS; Yule IA
    Bioorg Med Chem; 2009 Sep; 17(18):6590-605. PubMed ID: 19695884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.
    Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Nieto MI; Rodríguez-Borges JE
    Bioorg Med Chem; 2009 Sep; 17(18):6755-60. PubMed ID: 19682912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.
    Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Westerhout J; Spangenberg T; Brussee J; Ijzerman AP
    J Med Chem; 2007 Feb; 50(4):828-34. PubMed ID: 17300165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biaryl and heteroaryl derivatives of SCH 58261 as potent and selective adenosine A2A receptor antagonists.
    Shah U; Boyle CD; Chackalamannil S; Neustadt BR; Lindo N; Greenlee WJ; Foster C; Arik L; Zhai Y; Ng K; Wang S; Monopoli A; Lachowicz JE
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4199-203. PubMed ID: 18562199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of non-furan containing A2A antagonists using database mining and molecular similarity approaches.
    Richardson CM; Gillespie RJ; Williamson DS; Jordan AM; Fink A; Knight AR; Sellwood DM; Misra A
    Bioorg Med Chem Lett; 2006 Dec; 16(23):5993-7. PubMed ID: 16971117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives.
    Gillespie RJ; Adams DR; Bebbington D; Benwell K; Cliffe IA; Dawson CE; Dourish CT; Fletcher A; Gaur S; Giles PR; Jordan AM; Knight AR; Knutsen LJ; Lawrence A; Lerpiniere J; Misra A; Porter RH; Pratt RM; Shepherd R; Upton R; Ward SE; Weiss SM; Williamson DS
    Bioorg Med Chem Lett; 2008 May; 18(9):2916-9. PubMed ID: 18406614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of [1,2,4]triazolo[1,5-a]pyrazines as adenosine A2A receptor antagonists.
    Dowling JE; Vessels JT; Haque S; Chang HX; van Vloten K; Kumaravel G; Engber T; Jin X; Phadke D; Wang J; Ayyub E; Petter RC
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4809-13. PubMed ID: 16153830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidazo[2,1-i]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A(2A)- and A(3)-adenosine receptor antagonists.
    Müller CE; Thorand M; Qurishi R; Diekmann M; Jacobson KA; Padgett WL; Daly JW
    J Med Chem; 2002 Aug; 45(16):3440-50. PubMed ID: 12139454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.